Additional file 1: of Differences in response to antiretroviral therapy in HIV-positive patients being treated for tuberculosis in Eastern Europe, Western Europe and Latin America
- Yanink Caro-Vega (219578)
- Anna Schultze (431140)
- Anne W. Efsen (5132708)
- Frank Post (462543)
- Alexander Panteleev (840725)
- Aliaksandr Skrahin (840727)
- Jose Miro (2950623)
- Enrico Girardi (78640)
- Daria Podlekareva (5132705)
- Jens Lundgren (146550)
- Juan Sierra-Madero (210117)
- Javier Toibaro (840726)
- Jaime Andrade-Villanueva (196315)
- Simona Tetradov (5132699)
- Jan Fehr (174310)
- Joan Caylà (5132702)
- Marcelo Losso (4017368)
- Robert Miller (272785)
- Amanda Mocroft (288350)
- Ole Kirk (314889)
- Brenda Crabtree-Ramírez (219574)
DOIAbstract
Supplementary material response to ART in HIV-TB. Figure S1. Probability of death in efavirenz and non-efavirenz containing ART groups by inverse probability weighting method. Figure S2. Cox adjusted survival by ART regimen during the first year stratified by naïve status. Figure S3. Adjusted probability of death in the efavirenz group compared to the non-efavirenz group for naïve patients only. Table S1. Risk factors for death in naïve patients. Figure S4. Adjusted probability of death in the efavirenz group compared to the non-efavirenz group for non-naïve patients only. Table S2. Demographic and clinical characteristics of patients who never started ART at the time of starting TB treatment. Table S3. Risk factors for death in non-naïve p...
Add to ORKG